CSL’s Strategy In FY2026, CSL continued to execute against the 2030 strategy. As the global landscape evolves rapidly, CSL is constantly evaluating how to build on its historical strength, developing a treatment pipeline through a mix of research and development, business development and commercialisation. The leading positions CSL has built across the Therapeutic Areas (refer to pages 14–17 to read more on these) puts CSL in a unique position to continue to deliver for patients and public health systems while also generating financial returns that support reinvestment in long-term growth and shareholder returns. CSL’s strategy remains anchored in delivering enduring patient impact in areas of high unmet medical need. As CSL builds on its strong heritage in plasma therapies, it is focused on growth opportunities in therapeutic areas where it is best positioned to succeed, supported by a strategy of strengthening its core business, selective expansion, and disciplined capital allocation. This focused execution will enable CSL to convert its science, scale and global capabilities into sustainable growth and long-term value creation. VALUES THERAPEUTIC AREAS Strengthen core leadership in plasma, while expanding selectively into adjacencies where our science, capabilities and global scale provide a clear foundation for sustainable growth. VALUES CSL’s Values are at the core of how employees interact with each other, make decisions and solve problems. Patient Focus Make people and patients your passion Integrity Walk your talk Innovation Reach for the unreachable Superior Performance Make yourself proud Collaboration Adventure together Our Strategic Ambition To deliver enduring patient impact in areas of high unmet medical need The people and science of CSL save lives. CSL develops and delivers innovative medicines for patients who need durable, effective treatments for and protection from serious disease around the world. CSL’s Values guide the organisation in its aim of creating sustainable value for its stakeholders. PURPOSE 8 Performance
RkJQdWJsaXNoZXIy MjE2NDg3